Intractable heart failure despite angiotensin-converting enzyme inhibitors, digoxin, and diuretics: Long-term effectiveness of add-on therapy with pimobendan

This publication has 37 references indexed in Scilit:

• Cardiovascular Profile of UDCG 115 BS-Pimobendane and Reversibility of Catecholamine Subsensitivity in Severe Congestive Heart Failure Secondary to Idiopathic Dilated Cardiomyopathy
  Journal of Cardiovascular Pharmacology, 1989
• Pimobendan Increases Survival of Cardiomyopathic Hamsters
  Journal of Cardiovascular Pharmacology, 1989
• Pimobendan
  Cardiovascular Drug Reviews, 1988
• Influence of enoximone and UDCG-115 on coronary hemodynamics in idiopathic dilated cardiomyopathy
  The American Journal of Cardiology, 1988
• Pimobendane (UD-CG115 BS) in Chronic Congestive Heart Failure
  Chest, 1988
• Pimobendane (UD‐CG 115 BS) in the treatment of severe congestive heart failure. An acute haemodynamic cross‐over and double‐blind study with two different doses.
  British Journal of Clinical Pharmacology, 1988
• Cardiac and coronary vasodilator profile of pimobendan, a new cardiotonic drug, revealed by use of isolated, blood-perfused dog heart preparations
  Heart and Vessels, 1987
• Systemic haemodynamic actions of pimobendan (UD‐CG 115 BS) and its O‐demethylmetabolite UD‐CG 212 Cl in the conscious pig
  British Journal of Pharmacology, 1987
• Cardiovascular effects of UD-CG 212 CL, a metabolite of pimobendan, in anaesthetized pigs
  European Journal of Pharmacology, 1987
• UD-CG 115 ? a cardiotonic pyridazinone which elevates cyclic AMP and prolongs the action potential in guinea-pig papillary muscle
  Naunyn-Schmiedebergs Archiv für experimentelle Pathologie und Pharmakologie, 1984